MRMD today
$0.07+$0.00 (+4.75%)close Jun 25, 2026Trend
—
Key levels
—
Latest news & SEC filings
EarningsMariMed Discusses Third-Quarter 2026 Results on Call
SEC FilingMarimed Inc. filed a report on a major company event (Form 8-K)
EarningsMariMed Q3 EPS $(0.01) matches estimate; revenue $44.2M beats $41.2M estimate
All MRMD news →OTC · Healthcare
MARIMED INC. (MRMD)
What Is the Price Target for MRMD?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is MRMD a Buy or Sell Right Now?
Thesis
- •Revenue growing 1.3% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MRMD.
Start Free Trial →Is MRMD Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$0.53
19
Moat Score
NONE
3/9
Piotroski Score
-0.0
Altman Z-Score
What Is Smart Money Doing with MRMD?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Shaw Timothy | officer | Buy | 42,657 | - | Oct 15, 2026 |
| Shaw Timothy | officer | Sale | 12,520 | $751.20 | Oct 15, 2026 |
| Pinho Mario | officer | Buy | 38,282 | - | Oct 15, 2026 |
| Pinho Mario | officer | Sale | 11,236 | $674.16 | Oct 15, 2026 |
| Levine Jon R | director officer 10% owner | Buy | 30,625 | - | Oct 15, 2026 |
| Levine Jon R | director officer 10% owner | Sale | 8,989 | $539.34 | Oct 15, 2026 |
| Crandall Ryan | officer | Buy | 32,812 | - | Oct 15, 2026 |
| Crandall Ryan | officer | Sale | 9,631 | $577.86 | Oct 15, 2026 |
| Crandall Ryan | officer | Buy | 6,046 | - | Sep 28, 2026 |
| Crandall Ryan | officer | Sale | 2,095 | $161.32 | Sep 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MRMD Growth Story
Revenue YoY
1.3%
3yr Revenue CAGR
6.0%
EPS Growth YoY
-33.33%
FCF Growth YoY
226.1%
Revenue Trend
STABLE
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MARIMED INC. (MRMD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MRMD — frequently asked questions
What is MRMD stock price today?
MARIMED INC. (MRMD) is at $0.07, up 4.75% (+$0.00) at the Jun 25, 2026 close.
Why is MRMD stock moving today?
Latest MRMD news — Nov 12, 2026: MariMed Discusses Third-Quarter 2026 Results on Call · Nov 12, 2026: Marimed Inc. filed a report on a major company event (Form 8-K)
Did MRMD beat earnings?
MRMD last reported on Aug 12, 2026: EPS -$0.01 vs -$0.01 expected — a beat of 30.0%.
Does MRMD pay a dividend?
Yes. MRMD's dividend yield is 0.40%.
What are insiders doing with MRMD?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on MRMD?
Nov 12, 2026: MariMed Discusses Third-Quarter 2026 Results on Call · Nov 12, 2026: Marimed Inc. filed a report on a major company event (Form 8-K) · Nov 11, 2026: MariMed Q3 EPS $(0.01) matches estimate; revenue $44.2M beats $41.2M estimate